British Journal of Haematology | 2024
Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis.
Epperla N, Hashmi H, Ahn KW, Chen AI, Wirk B, Kanakry JA, Lekakis L, Lekakis L, Kharfan-Dabaja MA, Scordo M, Riedell PA, Jain T, Shadman M, Sauter C, Hamadani M, Herrera AF, Ahmed S
PubMed
PMID: 38797526
Abstract
Related Articles
CIBMTR Study #: LY22-02g